Calidi Biotherapeutics Launches Public Offering to Bolster Growth
Calidi Biotherapeutics launches underwritten public offering of common stock and warrants, with Ladenburg Thalmann managing the raise for working capital and corporate purposes.
CLDIwarrantspublic offering